Skip to content

Dr. Pooja Babbar

  • MBBS, MD, DM Medical Oncology
  • Consultant in the Department of Oncology

Education and Training:

  • MBBS from Maharashtra University of Health Science (MUHS)
  • MD Radiation Oncology and Senior Residency from Tata Memorial Hospital, Parel, Mumbai
  • DM Medical Oncology (Gold Medalist) from Kidwai Memorial Institute of Oncology, Bengaluru, Rajiv Gandhi University of Health Sciences (RGUHS)
  • European Certification in Medical Oncology by the European Society for Medical Oncology (ESMO)
  • Diploma in Medico Legal System
  • MBA in Hospital Management

Professional Experience:

  • Dr. Pooja has over 5 years of experience as a medical oncologist.
  • Expertise in oncology, including evaluation, diagnosis, staging, and personalized care plans for various solid and hematological malignancies.
  • Keeps abreast of the latest advancements in cancer guidelines and follows international protocols for cancer care.
  • Emphasizes a patient-centric approach and aims to provide comprehensive and holistic cancer care.

Achievements:

  • Gold medalist in DM Medical Oncology, RGUHS, with record-breaking marks and distinctions in 5 subjects.
  • Gold medalist in MBBS, MUHS.
  • Worked at premier cancer hospitals such as Tata Memorial Hospital, Mumbai, and Kidwai Memorial Institute of Oncology, Bengaluru.
  • Consultant in Medical Oncology at American Oncology Institute, Gurugram.

Areas of Interest:

  • Specializes in chemotherapy, immunotherapy, targeted therapy, and hormonal therapy.
  • Focuses on precision oncology, cancer screening, palliative care, and oncological emergencies.
  • Participates in multidisciplinary tumor board case discussions.

Expertise in head and neck cancers, thoracic malignancies, breast cancer, gynecological malignancies, gastrointestinal malignancies, genitourinary malignancies, solid malignancies, hematological malignancies, skin soft tissue, and bone tumors, endocrine and neuroendocrine neoplasms, neuro-oncology, lymphoma, multiple myeloma, and chronic leukemia.